SCHEMBL28022734

SCHEMBL28022734

CCCCCCCCC(OC(=O)Cl)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
NAAA Q02083 2/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ASAH1 Q13510 2/20 0.43
PRSS1 P07477 2/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
ACER2 Q5QJU3 1/20 0.42
POLB P06746 1/20 0.41
CNR2 P34972 1/20 0.41
LMNA P02545 1/20 0.41
CTSG P08311 1/20 0.40
CTRB1 P17538 1/20 0.40
CMA1 P23946 1/20 0.40
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP1 P03956 1/20 0.40
MMP3 P08254 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10660782 1.00 ALDH1A1 (0.48) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
SCHEMBL28050105 1.00 ALDH1A1 (0.48) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
Oxalic Acid SCHEMBL28200208 0.98 ALDH1A1 (0.47) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
SCHEMBL10661014 0.94 POLB (0.47) ALDH1A1NAAAPOLBCNR2
SCHEMBL1836778 0.88 ALDH1A1 (0.50) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
SCHEMBL1836595 0.88 ALDH1A1 (0.50) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
SCHEMBL1840792 0.88 ALDH1A1 (0.50) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
SCHEMBL1836596 0.88 ALDH1A1 (0.50) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
SCHEMBL1841905 0.88 ALDH1A1 (0.50) ALDH1A1NAAANPC1RAB9ASMN1; SMN2
SCHEMBL1836019 0.88 ALDH1A1 (0.50) ALDH1A1NAAANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102574857-B Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors LEO PHARMA AS 2015-06-10 CN claimed
CN-110300756-A Preparation method of 7H-pyrrolo [2,3-d ] pyrimidine derivative and synthetic intermediate thereof 日本烟草产业株式会社 2019-10-01 CN disclosed
CN-110099910-A Preparation method of 7H-pyrrolo [2,3-d ] pyrimidine derivative and eutectic crystal thereof 日本烟草产业株式会社 2019-08-06 CN disclosed
CN-105209470-B For treating and preventing the heteroaryl dihydro-pyrimidin of 6 hepatitis b virus infected bridgings 豪夫迈·罗氏有限公司 2018-02-06 CN disclosed
CN-104011054-B As the thieno of potassium channel inhibitors and Furanopyrimidines class and pyridines 森申有限公司 2016-08-24 CN disclosed
CN-105209470-A 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection HOFFMANN LA ROCHE 2015-12-30 CN disclosed
CN-102574857-B Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors LEO PHARMA AS 2015-06-10 CN disclosed